With Many More COVID-19 Vaccine Changes Ahead, ACIP Expecting Fewer Public Meetings
Executive Summary
CDC’s Advisory Committee on Immunization Practices wants a more feasible and sustainable meeting schedule in 2022, which would reduce transparency.
You may also be interested in...
Janssen COVID-19 Vaccine Adds Another Thrombotic Warning
US FDA adds a warning about immune thrombocytopenia, joining the risk of Thrombosis with Thrombocytopenia Syndrome.
Novavax Readies COVID-19 Vaccine Request For EUA, But How Much Longer Will The Door Be Open?
Availability of emergency authorization route in US depends upon lack of 'adequate, approved and available alternatives,' but as more vaccines make their way through the BLA process sponsors may find the EUA door slowly closing.
ACIP Upgrades Child Vaccine Booster Recommendation To ‘Should’
Not only should children age 12 to 15 get a booster, but 16- and 17-year-olds who previously 'may' get a booster, now also 'should' get one, the CDC advisory committee said.